London-based Lindus Health secures €16.5 million Series A to speed up clinical trials with machine learning
Summary
London and US-based startup Lindus Health has completed a €16.5 million Series A round to scale up and continue its mission of running innovative and radically faster end-to-end clinical trials for a range of conditions including depression, diabetes and insomnia. The funding comes from Spotify-backer Creandum, with participation from PayPal co-founder Peter Thiel and returning investors firstminute, Seedcamp, Hambro Perks and Amino Collective. With this latest funding round, Lindus Health will be expanding its technology platform to deliver more end-to-end clinical trials and higher quality data to research sponsors. Lead investor Creandum boasts an impressive portfolio of well-known companies, including Bolt, Klarna, Spotify, Depop, Tide, Trade Republic and Pleo. Fredrik Cassel, General Partner at Creandum, commented: “When we first met Michael, Meri and the rest of the Lindus Health team, we knew their approach to disrupting the clinical trials industry would be the right one.
Funding
Review available funding amount, funding date, investors, and linked company information related to London-based Lindus Health secures €16.5 million Series A to speed up clinical trials with machine learning in the interactive ISVWorld profile.